{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:40:02Z","timestamp":1790574002312,"version":"4.1.0"},"reference-count":172,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02188","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T07:58:48Z","timestamp":1568188728000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["The Rise of Coccidioides: Forces Against the Dust Devil Unleashed"],"prefix":"10.3389","volume":"10","author":[{"given":"Marley C. Caballero","family":"Van Dyke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"3rd","given":"George R.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Galgiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget M.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/CLEP.S34434","article-title":"Coccidioidomycosis: epidemiology","volume":"5","author":"Brown","year":"2013","journal-title":"Clin Epidemiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/cid\/cis1028","article-title":"Coccidioidomycosis acquired in Washington State","volume":"56","author":"Marsden-Haug","year":"2013","journal-title":"Clin Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/mmy\/myw017","article-title":"The epidemiology of fungemia in an infectious diseases hospital in Mexico city: a 10-year retrospective review","volume":"54","author":"Gaona-Flores","year":"2016","journal-title":"Med Mycol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1093\/mmy\/myy037","article-title":"Coccidioidomycosis in Latin America","volume":"57","author":"Laniado-Labor\u00edn","year":"2019","journal-title":"Med Mycol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mib.2019.05.002","article-title":"Fantastic yeasts and where to find them: the hidden diversity of dimorphic fungal pathogens","volume":"52","author":"Van Dyke","year":"2019","journal-title":"Curr Opin Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1128\/CMR.00005-13","article-title":"Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis","volume":"26","author":"Nguyen","year":"2013","journal-title":"Clin Microbiol Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3201\/eid2302.160505","article-title":"Risk factors for disseminated coccidioidomycosis, United States","volume":"23","author":"Odio","year":"2017","journal-title":"Emerg Infect Dis."},{"key":"B8","first-page":"2","article-title":"Pulmonary and extrapulmonary coccidioidomycosis, active component, U.S. Armed Forces, 1999-2011","volume":"19","author":"Mease","year":"2012","journal-title":"MSMR"},{"key":"B9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-1-4612-3730-3_6","article-title":"Epidemiology of coccidioidomycosis","volume":"2","author":"Pappagianis","year":"1988","journal-title":"Curr Top Med Mycol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2105\/AJPH.36.12.1394","article-title":"Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases","volume":"36","author":"Smith","year":"1946","journal-title":"Am J Public Health Nations Health."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3201\/eid1910.130427","article-title":"Coccidioidomycosis-associated hospitalizations, California, USA, 2000-2011","volume":"19","author":"Sondermeyer","year":"2013","journal-title":"Emerg Infect Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3201\/eid2101.140836","article-title":"Rates and risk factors for coccidioidomycosis among prison inmates, California, USA, 2011","volume":"21","author":"Wheeler","year":"2015","journal-title":"Emerg Infect Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e02634","DOI":"10.1128\/AAC.02634-16","article-title":"Large-scale evaluation of in vitro amphotericin B, triazole, and echinocandin activity against coccidioides species from U.S. Institutions","volume":"61","author":"Thompson","year":"2017","journal-title":"Antimicrob Agents Chemother."},{"key":"B15","first-page":"217","article-title":"Increase in reported coccidioidomycosis\u2013United States, 1998-2011","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B16","article-title":"Overview of endemic mycoses","volume-title":"Vaccine Strategies for Endemic Fungal Pathogens","author":"Chiller","year":"2019"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1004762","DOI":"10.1371\/journal.ppat.1004762","article-title":"Dust devil: the life and times of the fungus that causes valley Fever","volume":"11","author":"Lewis","year":"2015","journal-title":"PLoS Pathog."},{"key":"B18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nrmicro.2015.21","article-title":"Interactions of fungal pathogens with phagocytes","volume":"14","author":"Erwig","year":"2016","journal-title":"Nat Rev Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1128\/IAI.01579-13","article-title":"Interleukin-1 receptor but not Toll-like receptor 2 is essential for MyD88-dependent Th17 immunity to Coccidioides infection","volume":"82","author":"Hung","year":"2014","journal-title":"Infect Immun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0129522","DOI":"10.1371\/journal.pone.0129522","article-title":"Coccidioides endospores and spherules draw strong chemotactic, adhesive, and phagocytic responses by individual human neutrophils","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS ONE."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1242\/jcs.02876","article-title":"Mechanics of neutrophil phagocytosis: experiments and quantitative models","volume":"119","author":"Herant","year":"2006","journal-title":"J Cell Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1128\/IAI.05726-11","article-title":"Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17)","volume":"79","author":"Hung","year":"2011","journal-title":"Infect Immun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/infdis\/147.3.372","article-title":"Coccidioidomycosis: factors affecting the host-parasite interaction","volume":"147","author":"Drutz","year":"1983","journal-title":"J Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1128\/IAI.01066-15","article-title":"Card9- and MyD88-mediated gamma interferon and nitric oxide production is essential for resistance to subcutaneous Coccidioides posadasii infection","volume":"84","author":"Hung","year":"2016","journal-title":"Infect Immun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.micpath.2011.08.003","article-title":"Absence of phagocyte NADPH oxidase 2 leads to severe inflammatory response in lungs of mice infected with Coccidioides","volume":"51","author":"Gonzalez","year":"2011","journal-title":"Microb Pathog."},{"key":"B26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.micpath.2011.03.013","article-title":"Nitric oxide synthase activity has limited influence on the control of Coccidioides infection in mice","volume":"51","author":"Gonzalez","year":"2011","journal-title":"Microb Pathog."},{"key":"B27","first-page":"1","article-title":"Macrophage heterogeneity","volume":"14","author":"Dougherty","year":"1984","journal-title":"J Clin Lab Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s11095-008-9562-y","article-title":"Role of particle size in phagocytosis of polymeric microspheres","volume":"25","author":"Champion","year":"2008","journal-title":"Pharm Res."},{"key":"B29","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1128\/IAI.57.7.1916-1921.1989","article-title":"Induction of tumor necrosis factor alpha by spherules of Coccidioides immitis","volume":"57","author":"Slagle","year":"1989","journal-title":"Infect Immun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/infdis\/jit246","article-title":"Immunological characterization of bronchoalveolar lavage fluid in patients with acute pulmonary coccidioidomycosis","volume":"208","author":"Nesbit","year":"2013","journal-title":"J Infect Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1128\/IAI.73.3.1553-1560.2005","article-title":"Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and Dectin-1","volume":"73","author":"Viriyakosol","year":"2005","journal-title":"Infect Immun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e00597","DOI":"10.1128\/mBio.00597-12","article-title":"Dectin-1 is required for resistance to coccidioidomycosis in mice","volume":"4","author":"Viriyakosol","year":"2013","journal-title":"MBio"},{"key":"B33","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/gene.2008.23","article-title":"Susceptibility to Coccidioides species in C57BL\/6 mice is associated with expression of a truncated splice variant of Dectin-1 (Clec7a)","volume":"9","author":"del Pilar Jim\u00e9nez-A","year":"2008","journal-title":"Genes Immun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1056\/NEJMoa0901053","article-title":"Human dectin-1 deficiency and mucocutaneous fungal infections","volume":"361","author":"Ferwerda","year":"2009","journal-title":"N Engl J Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1056\/NEJMoa1208487","article-title":"Deep dermatophytosis and inherited CARD9 deficiency","volume":"369","author":"Lanternier","year":"2013","journal-title":"N Engl J Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1196\/annals.1406.032","article-title":"The complex immunology of human coccidioidomycosis","volume":"1111","author":"Ampel","year":"2007","journal-title":"Ann N Y Acad Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11046-008-9172-6","article-title":"Mannose-binding lectin serum levels are low in persons with clinically active coccidioidomycosis","volume":"167","author":"Ampel","year":"2009","journal-title":"Mycopathologia."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1128\/IAI.01355-13","article-title":"Neither dectin-2 nor the mannose receptor is required for resistance to Coccidioides immitis in mice","volume":"82","author":"Viriyakosol","year":"2014","journal-title":"Infect Immun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e00028","DOI":"10.1128\/IAI.00028-18","article-title":"Myeloid differentiation factor 88 and interleukin-1R1 signaling contribute to resistance to Coccidioides immitis","volume":"86","author":"Viriyakosol","year":"2018","journal-title":"Infect Immun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chom.2012.04.005","article-title":"Dendritic cells in antifungal immunity and vaccine design","volume":"11","author":"Roy","year":"2012","journal-title":"Cell Host Microbe."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1086\/323664","article-title":"Dendritic cells pulsed with Coccidioides immitis lysate induce antigen-specific naive T cell activation","volume":"184","author":"Richards","year":"2001","journal-title":"J Infect Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.4049\/jimmunol.169.4.2020","article-title":"Reversal of coccidioidal anergy in vitro by dendritic cells from patients with disseminated coccidioidomycosis","volume":"169","author":"Richards","year":"2002","journal-title":"J Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cellimm.2004.11.006","article-title":"Differences in expression of cell surface co-stimulatory molecules, Toll-like receptor genes and secretion of IL-12 by bone marrow-derived dendritic cells from susceptible and resistant mouse strains in response to Coccidioides posadasii","volume":"231","author":"Awasthi","year":"2004","journal-title":"Cell Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1073\/pnas.071406098","article-title":"Biogeographic range expansion into South America by Coccidioides immitis mirrors New World patterns of human migration","volume":"98","author":"Fisher","year":"2001","journal-title":"Proc Natl Acad Sci USA."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1128\/EC.00122-15","article-title":"Differences in host innate responses among Coccidioides isolates in a murine model of pulmonary coccidioidomycosis","volume":"14","author":"Lewis","year":"2015","journal-title":"Eukaryot Cell."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1128\/IAI.70.7.3443-3456.2002","article-title":"A parasitic phase-specific adhesin of Coccidioides immitis contributes to the virulence of this respiratory Fungal pathogen","volume":"70","author":"Hung","year":"2002","journal-title":"Infect Immun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1128\/IAI.68.2.584-593.2000","article-title":"A major cell surface antigen of Coccidioides immitis which elicits both humoral and cellular immune responses","volume":"68","author":"Hung","year":"2000","journal-title":"Infect Immun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"6689","DOI":"10.1128\/IAI.73.10.6689-6703.2005","article-title":"A metalloproteinase of Coccidioides posadasii contributes to evasion of host detection","volume":"73","author":"Hung","year":"2005","journal-title":"Infect Immun."},{"key":"B49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.micpath.2010.11.006","article-title":"Coccidioides releases a soluble factor that suppresses nitric oxide production by murine primary macrophages","volume":"50","author":"Gonzalez","year":"2011","journal-title":"Microb Pathog."},{"key":"B50","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12281-012-0105-y","article-title":"Progress toward a human vaccine against coccidioidomycosis","volume":"6","author":"Cole","year":"2012","journal-title":"Curr Fungal Infect Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1128\/IAI.00459-09","article-title":"A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB\/c mice against coccidioidomycosis","volume":"77","author":"Xue","year":"2009","journal-title":"Infect Immun."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1016\/j.vaccine.2005.01.147","article-title":"Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection","volume":"23","author":"Xue","year":"2005","journal-title":"Vaccine."},{"key":"B53","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1128\/IAI.00953-09","article-title":"Polyfunctional T lymphocytes are in the peripheral blood of donors naturally immune to coccidioidomycosis and are not induced by dendritic cells","volume":"78","author":"Nesbit","year":"2010","journal-title":"Infect Immun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1086\/605532","article-title":"Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-gamma receptor 1 deficiency","volume":"49","author":"Vinh","year":"2009","journal-title":"Clin Infect Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1093\/cid\/ciq215","article-title":"Interleukin-12 receptor beta1 deficiency predisposing to disseminated coccidioidomycosis","volume":"52","author":"Vinh","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1128\/IAI.73.10.7011-7013.2005","article-title":"Role of B cells in vaccine-induced immunity against coccidioidomycosis","volume":"73","author":"Magee","year":"2005","journal-title":"Infect Immun."},{"key":"B57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/13693780410001687349","article-title":"A vaccine against coccidioidomycosis is justified and attainable","volume":"42","author":"Cole","year":"2004","journal-title":"Med Mycol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1093\/cid\/civ585","article-title":"Role of Coccidioides antigen testing in the cerebrospinal fluid for the diagnosis of coccidioidal meningitis","volume":"61","author":"Kassis","year":"2015","journal-title":"Clin Infect Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00281-009-0191-2","article-title":"Th17 cytokines and vaccine-induced immunity","volume":"32","author":"Lin","year":"2010","journal-title":"Semin Immunopathol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1086\/502972","article-title":"Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice","volume":"193","author":"Fierer","year":"2006","journal-title":"J Infect Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e1002771","DOI":"10.1371\/journal.ppat.1002771","article-title":"Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells","volume":"8","author":"Nanjappa","year":"2012","journal-title":"PLoS Pathog."},{"key":"B62","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1172\/JCI58762","article-title":"Protective antifungal memory CD8(+) T cells are maintained in the absence of CD4(+) T cell help and cognate antigen in mice","volume":"122","author":"Nanjappa","year":"2012","journal-title":"J Clin Invest."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1084\/jem.20030109","article-title":"Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts","volume":"197","author":"Wuthrich","year":"2003","journal-title":"J Exp Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1016\/j.jaci.2018.10.022","article-title":"Elevated regulatory T cells at diagnosis of Coccidioides infection associates with chronicity in pediatric patients","volume":"142","author":"Davini","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis-A phase 2 randomized, double-blind, placebo-controlled trial","volume":"66","author":"Edwards","year":"2018","journal-title":"Clin Infect Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"E34","DOI":"10.3390\/jof2040034","article-title":"The quest for a vaccine against coccidioidomycosis: a neglected disease of the Americas","volume":"2","author":"Kirkland","year":"2016","journal-title":"J Fungi (Basel)."},{"key":"B67","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.2164-0947.1960.tb00711.x","article-title":"Immunity to coccidioi-domycosis induced in mice by purified spherule, arthrospore, and mycelial vaccines","volume":"22","author":"Levine","year":"1960","journal-title":"Trans N Y Acad Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1164\/ajrccm\/148.3.656","article-title":"Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group","volume":"148","author":"Pappagianis","year":"1993","journal-title":"Am Rev Respir Dis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1128\/CVI.00480-08","article-title":"Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis","volume":"16","author":"Saville","year":"2009","journal-title":"Clin Vaccine Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.3389\/fimmu.2017.01359","article-title":"Induction of broad-spectrum protective immunity against disparate Cryptococcus serotypes","volume":"8","author":"Van Dyke","year":"2017","journal-title":"Front Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1128\/IAI.00274-06","article-title":"Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain","volume":"75","author":"Wormley","year":"2007","journal-title":"Infect Immun."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e6854","DOI":"10.1371\/journal.pone.0006854","article-title":"Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis","volume":"4","author":"Wozniak","year":"2009","journal-title":"PLoS ONE."},{"key":"B73","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/ni0504-460","article-title":"Vaccine development strategies for improving immunization: the role of modern immunology","volume":"5","author":"Levine","year":"2004","journal-title":"Nat Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1128\/IAI.01148-13","article-title":"Vaccinated C57BL\/6 mice develop protective and memory T cell responses to Coccidioides posadasii infection in the absence of interleukin-10","volume":"82","author":"Hung","year":"2014","journal-title":"Infect Immun."},{"key":"B75","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.1073\/pnas.0931375100","article-title":"A novel class of gene controlling virulence in plant pathogenic ascomycete fungi","volume":"100","author":"Lu","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B76","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1128\/IAI.00633-16","article-title":"A Coccidioides posadasii CPS1 deletion mutant is avirulent and protects mice from lethal infection","volume":"84","author":"Narra","year":"2016","journal-title":"Infect Immun."},{"key":"B77","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1016\/j.vaccine.2018.04.026","article-title":"Viable spores of Coccidioides posadasii Deltacps1 are required for vaccination and provide long lasting immunity","volume":"36","author":"Shubitz","year":"2018","journal-title":"Vaccine."},{"key":"B78","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1086\/529205","article-title":"Vaccines to prevent systemic mycoses: holy grails meet translational realities","volume":"197","author":"Galgiani","year":"2008","journal-title":"J Infect Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.11.1.1","article-title":"Use of licensed vaccines for active immunization of the immunocompromised host","volume":"11","author":"Pirofski","year":"1998","journal-title":"Clin Microbiol Rev."},{"key":"B80","article-title":"A canine target species challenge model to evaluate efficacy of a coccidioidomycosis vaccine","volume-title":"Infectious Diseases of Society of America","author":"Shubitz","year":"2019"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3390\/ijerph16071113","article-title":"The rise of valley fever: prevalence and cost burden of coccidioidomycosis infection in California","volume":"16","author":"Wilson","year":"2019","journal-title":"Int J Environ Res Public Health."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2012.02.012","article-title":"Beyond empiricism: informing vaccine development through innate immunity research","volume":"148","author":"Levitz","year":"2012","journal-title":"Cell."},{"key":"B83","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1016\/j.vaccine.2012.04.084","article-title":"An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection","volume":"30","author":"Hung","year":"2012","journal-title":"Vaccine."},{"key":"B84","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1016\/j.vaccine.2006.04.002","article-title":"Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein","volume":"24","author":"Shubitz","year":"2006","journal-title":"Vaccine."},{"key":"B85","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.1128\/IAI.00961-06","article-title":"Multivalent recombinant protein vaccine against coccidioidomycosis","volume":"74","author":"Tarcha","year":"2006","journal-title":"Infect Immun."},{"key":"B86","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1128\/IAI.74.1.516-527.2006","article-title":"A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice","volume":"74","author":"Tarcha","year":"2006","journal-title":"Infect Immun."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1128\/IAI.70.7.3539-3545.2002","article-title":"Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis","volume":"70","author":"Jiang","year":"2002","journal-title":"Infect Immun."},{"key":"B88","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/IAI.67.2.630-635.1999","article-title":"Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA","volume":"67","author":"Jiang","year":"1999","journal-title":"Infect Immun."},{"key":"B89","doi-asserted-by":"publisher","first-page":"5777","DOI":"10.1128\/IAI.00807-07","article-title":"Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis","volume":"75","author":"Herr","year":"2007","journal-title":"Infect Immun."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.vaccine.2019.01.034","article-title":"Dendritic cell-based immunization induces Coccidioides Ag2\/PRA-specific immune response","volume":"37","author":"Awasthi","year":"2019","journal-title":"Vaccine."},{"key":"B91","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.4049\/jimmunol.175.6.3900","article-title":"Efficacy of antigen 2\/proline-rich antigen cDNA-transfected dendritic cells in immunization of mice against Coccidioides posadasii","volume":"175","author":"Awasthi","year":"2005","journal-title":"J Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1128\/IAI.74.3.1865-1872.2006","article-title":"Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate","volume":"74","author":"Orsborn","year":"2006","journal-title":"Infect Immun."},{"key":"B93","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00005-010-0067-0","article-title":"CD4+ T cell epitope discovery and rational vaccine design","volume":"58","author":"Rosa","year":"2010","journal-title":"Arch Immunol Ther Exp (Warsz)."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e1003768","DOI":"10.1371\/journal.ppat.1003768","article-title":"Novel strategies to enhance vaccine immunity against coccidioidomycosis","volume":"9","author":"Cole","year":"2013","journal-title":"PLoS Pathog"},{"key":"B95","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1128\/IAI.00566-12","article-title":"Construction and evaluation of a novel recombinant T cell epitope-based vaccine against coccidioidomycosis","volume":"80","author":"Hurtgen","year":"2012","journal-title":"Infect Immun."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1080\/15287390701212224","article-title":"A comparison of the pulmonary inflammatory potential of different components of yeast cell wall","volume":"70","author":"Young","year":"2007","journal-title":"J Toxicol Environ Health A."},{"key":"B97","doi-asserted-by":"publisher","first-page":"e00070","DOI":"10.1128\/IAI.00070-18","article-title":"Glucan-chitin particles enhance Th17 response and improve protective efficacy of a multivalent antigen (rCpa1) against pulmonary Coccidioides posadasii infection","volume":"86","author":"Hung","year":"2018","journal-title":"Infect Immun."},{"key":"B98","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/infdis\/jiz196","article-title":"Maize-produced Ag2 as a subunit vaccine for valley fever","volume":"220","author":"Hayden","year":"2019","journal-title":"J Infect Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3201\/eid2006.131842","article-title":"Characteristics of patients with mild to moderate primary pulmonary coccidioidomycosis","volume":"20","author":"Blair","year":"2014","journal-title":"Emerg Infect Dis."},{"key":"B100","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1093\/mmy\/myy029","article-title":"Current concepts and future directions in the pharmacology and treatment of coccidioidomycosis","volume":"57","author":"Thompson","year":"2019","journal-title":"Med Mycol."},{"key":"B101","first-page":"339","article-title":"Coccidioidal meningitis. The use of amphotericin B in treatment","volume":"94","author":"Einstein","year":"1961","journal-title":"Calif Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1086\/374553","article-title":"Triad of acute infusion-related reactions associated with liposomal amphotericin B: analysis of clinical and epidemiological characteristics","volume":"36","author":"Roden","year":"2003","journal-title":"Clin Infect Dis."},{"key":"B103","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1681\/ASN.V62154","article-title":"Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties","volume":"6","author":"Sawaya","year":"1995","journal-title":"J Am Soc Nephrol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1172\/JCI115240","article-title":"Direct vasoconstriction as a possible cause for amphotericin B-induced nephrotoxicity in rats","volume":"87","author":"Sawaya","year":"1991","journal-title":"J Clin Invest."},{"key":"B105","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1182\/blood-2005-06-2564","article-title":"Amphotericin B blunts erythropoietin response to hypoxia by reinforcing FIH-mediated repression of HIF-1","volume":"107","author":"Yeo","year":"2006","journal-title":"Blood."},{"key":"B106","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/02681219480000621","article-title":"Efficacy of AmBisome in murine coccidioidomycosis","volume":"32","author":"Albert","year":"1994","journal-title":"J Med Vet Mycol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1128\/AAC.01538-08","article-title":"Comparative efficacies of lipid-complexed amphotericin B and liposomal amphotericin B against coccidioidal meningitis in rabbits","volume":"53","author":"Clemons","year":"2009","journal-title":"Antimicrob Agents Chemother."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1128\/AAC.46.8.2420-2426.2002","article-title":"Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits","volume":"46","author":"Clemons","year":"2002","journal-title":"Antimicrob Agents Chemother."},{"key":"B109","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1128\/AAC.48.6.2140-2143.2004","article-title":"Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis","volume":"48","author":"Gonz\u00e1lez","year":"2004","journal-title":"Antimicrob Agents Chemother."},{"key":"B110","doi-asserted-by":"publisher","first-page":"e02293","DOI":"10.1128\/AAC.02293-17","article-title":"Evaluation of amphotericin B lipid formulations for treatment of severe coccidioidomycosis","volume":"62","author":"Sidhu","year":"2018","journal-title":"Antimicrob Agents Chemother."},{"key":"B111","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/MD.0b013e3181f378a8","article-title":"Coccidioidal meningitis: clinical presentation and management in the fluconazole era","volume":"89","author":"Mathisen","year":"2010","journal-title":"Medicine (Baltimore)."},{"key":"B112","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/mmy\/myv047","article-title":"In vitro interactions between amphotericin B and hydrocortisone: potential implications for intrathecal therapy","volume":"53","author":"Hodge","year":"2015","journal-title":"Med Mycol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1053\/srin.2001.29298","article-title":"Intrathecal amphotericin in the management of coccidioidal meningitis","volume":"16","author":"Stevens","year":"2001","journal-title":"Semin Respir Infect."},{"key":"B114","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0009-2797(78)90068-6","article-title":"Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans","volume":"21","author":"van den Bossche","year":"1978","journal-title":"Chem Biol Interact."},{"key":"B115","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/infdis\/157.1.178","article-title":"Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system","volume":"157","author":"Arndt","year":"1988","journal-title":"J Infect Dis."},{"key":"B116","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/jac\/dky501","article-title":"Tolerability of long-term fluconazole therapy","volume":"74","author":"Davis","year":"2019","journal-title":"J Antimicrob Chemother."},{"key":"B117","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1128\/AAC.34.5.928","article-title":"Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis","volume":"34","author":"Clemons","year":"1990","journal-title":"Antimicrob Agents Chemother."},{"key":"B118","doi-asserted-by":"publisher","first-page":"676","DOI":"10.7326\/0003-4819-133-9-200011070-00009","article-title":"Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group","volume":"133","author":"Galgiani","year":"2000","journal-title":"Ann Intern Med."},{"key":"B119","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.taap.2013.01.029","article-title":"Itraconazole decreases left ventricular contractility in isolated rabbit heart: mechanism of action","volume":"268","author":"Qu","year":"2013","journal-title":"Toxicol Appl Pharmacol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/myc.12749","article-title":"Itraconazole induced hypertension and hypokalemia: Mechanistic evaluation","volume":"61","author":"Hoffmann","year":"2018","journal-title":"Mycoses."},{"key":"B121","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/jac\/16.1.81","article-title":"Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits","volume":"16","author":"Perfect","year":"1985","journal-title":"J Antimicrob Chemother."},{"key":"B122","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1093\/clinids\/9.Supplement_1.S43","article-title":"Itraconazole: pharmacologic studies in animals and humans","volume":"9","author":"Van Cauteren","year":"1987","journal-title":"Rev Infect Dis."},{"key":"B123","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1128\/AAC.00963-13","article-title":"Amphotericin B-impregnated bone cement to treat refractory coccidioidal osteomyelitis","volume":"57","author":"Zhu","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"key":"B124","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1128\/AAC.00705-08","article-title":"Antifungal therapeutic drug monitoring: established and emerging indications","volume":"53","author":"Andes","year":"2009","journal-title":"Antimicrob Agents Chemother."},{"key":"B125","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1128\/AAC.00332-06","article-title":"Comparison of itraconazole and fluconazole treatments in a murine model of coccidioidal meningitis","volume":"51","author":"Kamberi","year":"2007","journal-title":"Antimicrob Agents Chemother."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1128\/AAC.44.6.1512-1517.2000","article-title":"Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis","volume":"44","author":"Sorensen","year":"2000","journal-title":"Antimicrob Agents Chemother."},{"key":"B127","doi-asserted-by":"publisher","first-page":"108","DOI":"10.7326\/0003-4819-112-2-108","article-title":"Itraconazole therapy for chronic coccidioidal meningitis","volume":"112","author":"Tucker","year":"1990","journal-title":"Ann Intern Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1086\/497596","article-title":"Coccidioidal meningitis","volume":"42","author":"Johnson","year":"2006","journal-title":"Clin Infect Dis."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/cid\/cir642","article-title":"Treatment of refractory coccidioidomycosis with voriconazole or posaconazole","volume":"53","author":"Kim","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1128\/AAC.01148-07","article-title":"Voriconazole use for endemic fungal infections","volume":"53","author":"Freifeld","year":"2009","journal-title":"Antimicrob Agents Chemother."},{"key":"B131","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2133.2012.11196.x","article-title":"Voriconazole-induced photosensitivity: photobiological assessment of a case series of 12 patients","volume":"168","author":"Haylett","year":"2013","journal-title":"Br J Dermatol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"5058","DOI":"10.1167\/iovs.11-7183","article-title":"Mechanism of voriconazole-induced transient visual disturbance: reversible dysfunction of retinal ON-bipolar cells in monkeys","volume":"52","author":"Kinoshita","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciu275","article-title":"Alopecia and nail changes associated with voriconazole therapy","volume":"59","author":"Malani","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B134","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1086\/524669","article-title":"Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes","volume":"46","author":"Pascual","year":"2008","journal-title":"Clin Infect Dis."},{"key":"B135","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/myc.12517","article-title":"Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether beta-cyclodextrin in haematological patients with renal impairment","volume":"59","author":"Kim","year":"2016","journal-title":"Mycoses."},{"key":"B136","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1128\/AAC.00240-09","article-title":"Posaconazole therapeutic drug monitoring: a reference laboratory experience","volume":"53","author":"Thompson","year":"2009","journal-title":"Antimicrob Agents Chemother."},{"key":"B137","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/myc.12452","article-title":"Comparison of posaconazole serum concentrations from haematological cancer patients on posaconazole tablet and oral suspension for treatment and prevention of invasive fungal infections","volume":"59","author":"Pham","year":"2016","journal-title":"Mycoses."},{"key":"B138","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/bmt.2009.17","article-title":"Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis","volume":"44","author":"Reinwald","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1093\/jac\/dkn409","article-title":"Posaconazole concentrations in the central nervous system","volume":"62","author":"R\u00fcping","year":"2008","journal-title":"J Antimicrob Chemother."},{"key":"B140","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1086\/519937","article-title":"Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis","volume":"45","author":"Catanzaro","year":"2007","journal-title":"Clin Infect Dis."},{"key":"B141","doi-asserted-by":"publisher","first-page":"e00760","DOI":"10.1128\/AAC.00760-17","article-title":"In vivo 11beta-hydroxysteroid dehydrogenase inhibition in posaconazole-induced hypertension and hypokalemia","volume":"61","author":"Thompson","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz741","article-title":"Posaconazole serum drug levels associated with pseudohyperaldosteronism","author":"Nguyen","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B143","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1128\/AAC.46.5.1352-1356.2002","article-title":"In vitro and in vivo activities of posaconazole against Coccidioides immitis","volume":"46","author":"Gonz\u00e1lez","year":"2002","journal-title":"Antimicrob Agents Chemother."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1128\/AAC.41.7.1558","article-title":"Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis","volume":"41","author":"Lutz","year":"1997","journal-title":"Antimicrob Agents Chemother."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1086\/430303","article-title":"Refractory coccidioidomycosis treated with posaconazole","volume":"40","author":"Anstead","year":"2005","journal-title":"Clin Infect Dis."},{"key":"B147","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1378\/chest.07-0114","article-title":"Posaconazole therapy for chronic refractory coccidioidomycosis","volume":"132","author":"Stevens","year":"2007","journal-title":"Chest."},{"key":"B148","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/IDR.S81416","article-title":"Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections","volume":"9","author":"Donnelley","year":"2016","journal-title":"Infect Drug Resist."},{"key":"B149","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet."},{"key":"B150","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis."},{"key":"B151","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/cid\/ciw305","article-title":"Isavuconazole treatment of cryptococcosis and dimorphic mycoses","volume":"63","author":"Thompson","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B152","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.1128\/AAC.00229-16","article-title":"isavuconazole is effective for the treatment of experimental cryptococcal meningitis","volume":"60","author":"Wiederhold","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"key":"B153","doi-asserted-by":"publisher","first-page":"e02232","DOI":"10.1128\/AAC.02232-18","article-title":"Isavuconazole in the treatment of coccidioidal meningitis","volume":"63","author":"Heidari","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/jac\/dkm383","article-title":"Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model","volume":"60","author":"Gonz\u00e1lez","year":"2007","journal-title":"J Antimicrob Chemother."},{"key":"B155","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/13693780500147840","article-title":"Coccidioidomycosis in hematopoietic stem cell transplant recipients","volume":"43","author":"Glenn","year":"2005","journal-title":"Med Mycol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/cid\/cit113","article-title":"Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series","volume":"56","author":"Levy","year":"2013","journal-title":"Clin Infect Dis."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1093\/cid\/cit114","article-title":"Pediatric coccidioidomycosis in central California: a retrospective case series","volume":"56","author":"McCarty","year":"2013","journal-title":"Clin Infect Dis."},{"key":"B158","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1093\/jac\/dkx295","article-title":"Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation","volume":"72","author":"Lindsay","year":"2017","journal-title":"J Antimicrob Chemother."},{"key":"B159","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-1-4939-6515-1_5","article-title":"Systemic antifungal agents: current status and projected future developments","volume":"1508","author":"Seyedmousavi","year":"2017","journal-title":"Methods Mol Biol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"e00999","DOI":"10.1128\/AAC.00999-18","article-title":"The orotomide olorofim is efficacious in an experimental model of central nervous system coccidioidomycosis","volume":"62","author":"Wiederhold","year":"2018","journal-title":"Antimicrob Agents Chemother."},{"key":"B161","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1128\/AAC.05414-11","article-title":"Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods","volume":"56","author":"Castanheira","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"B162","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1128\/AAC.00291-11","article-title":"In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds","volume":"55","author":"Miyazaki","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"B163","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1128\/AAC.00570-11","article-title":"In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods","volume":"55","author":"Pfaller","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"B164","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.diagmicrobio.2011.05.001","article-title":"In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method","volume":"71","author":"Pfaller","year":"2011","journal-title":"Diagn Microbiol Infect Dis."},{"key":"B165","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1093\/jac\/dkr342","article-title":"Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods","volume":"66","author":"Pfaller","year":"2011","journal-title":"J Antimicrob Chemother."},{"key":"B166","doi-asserted-by":"publisher","first-page":"e00523","DOI":"10.1128\/AAC.00523-18","article-title":"In vitro and in vivo evaluation of APX001A\/APX001 and other Gwt1 inhibitors against cryptococcus","volume":"62","author":"Shaw","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"B167","doi-asserted-by":"publisher","first-page":"e01715","DOI":"10.1128\/AAC.01715-18","article-title":"APX001 and other Gwt1 inhibitor prodrugs are effective in experimental Coccidioides immitis pneumonia","volume":"63","author":"Viriyakosol","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1093\/infdis\/jiu029","article-title":"Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials","volume":"209","author":"Shubitz","year":"2014","journal-title":"J Infect Dis."},{"key":"B169","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/AAC.34.4.587","article-title":"Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis","volume":"34","author":"Hector","year":"1990","journal-title":"Antimicrob Agents Chemother."},{"key":"B170","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/IDR.S124918","article-title":"Antifungal resistance: current trends and future strategies to combat","volume":"10","author":"Wiederhold","year":"2017","journal-title":"Infect Drug Resist."},{"key":"B171","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/mmy\/myw060","article-title":"The anti-Aspergillus drug pipeline: is the glass half full or empty?","volume":"55","author":"Osherov","year":"2017","journal-title":"Med Mycol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/21501203.2016.1204368","article-title":"Sertraline demonstrates fungicidal activity in vitro for Coccidioides immitis","volume":"7","author":"Paul","year":"2016","journal-title":"Mycology."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02188\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T04:41:54Z","timestamp":1664340114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02188\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,11]]},"references-count":172,"alternative-id":["10.3389\/fimmu.2019.02188"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02188","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,11]]},"article-number":"2188"}}